3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Myelodysplastic Syndromes
17
Multiple Myeloma
13
Lymphoma, Non-Hodgkin
13
Hodgkin Disease
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Leukemia, Lymphocytic, Chronic, B-Cell
10
Myeloproliferative Disorders
9
Melanoma
8
Recurrence
7
Leukemia, Myelomonocytic, Chronic
7
Leukemia, Biphenotypic, Acute
7
Anemia, Refractory, with Excess of Blasts
7
Lymphoma
6
Leukemia
6
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Waldenstrom Macroglobulinemia
4
Neuroblastoma
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myelomonocytic, Juvenile
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Burkitt Lymphoma
4
Uveal Melanoma
3
Stomach Neoplasms
3
Primary Myelofibrosis
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Interventions
Tretinoin
3
Arsenic Trioxide
3
arsenous acid
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Magnetic Resonance Spectroscopy
1
Lisaftoclax
1
Idarubicin
1
Gemtuzumab
1
Gadolinium
1
Fluorodeoxyglucose F18
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Promyelocytic, Acute
×
fludarabine phosphate
×
90 days
×
Clear all
No trials found.